Research
>
STROKE RESEARCH
Research
on Acute Stroke Treatments
The treatment of acute stroke is a very recent, rapidly evolving area
of
research. The
Vanderbilt Stroke Center
has been involved in research on
the clot-dissolving drug, tissue-type thromboplastin activator (tPA) since
1992. Since 1996, intravenous tPA has been an approved treatment for
acute, ischemic stroke. Vanderbilt Medical Center has an active stroke
team,
involved in screening and treatment of patients within the three-hour
time
window after onset of stroke symptoms. For selected patients up to
six hours after onset, tPA can be given through an arterial catheter
near the site of clot in a brain artery. This investigational therapy
is
offered in conjunction with Interventional Neuroradiology. The
Vanderbilt Stroke Center has also participated in several trials of
"neuroprotective" agents designed to reduce the development
of
brain damage after acute stroke.
Please also visit
Dr.
McLaughlin's URL to learn more about basic research in stroke.
If you are interested
in applying for a faculty position in the stroke division, please visit:
http://www.mc.vanderbilt.edu/neurology/strokeposition.htm.
Research in Stroke Prevention
Please contact Diane Brown,
R.N., at 615-936-0062 for further information about stroke studies.
Please also visit
http://www.vanderbiltstrokecenter.com
for more information on stroke.
|
